arrow
S

Sandrine Aspeslagh

institut jules bordet
H指数:35
被引数:4,444

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer

糖皮质激素和二线免疫抑制剂对非小细胞肺癌免疫相关不良事件后检查点抑制剂的有效性

2026-01-200
OAAI
Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
2024-08-014
PRE
Corticosteroids and second-line immunosuppressants for immune-related adverse events and melanoma survival
2023-10-011
OA
Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)
2023-07-2017
OAAI
Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus

关于通过多学科改良Delphi共识管理免疫检查点抑制剂诱导的结肠炎的立场声明

2023-07-014
PRE
Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future
2022-12-011
OAAI
Assessment of repeatability and uptake quantification of 68GaNOTA-anti-HER2 sdAb PET/CT in patients with locally advanced or metastatic breast cancer
2022-02-150
PRE
Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune- checkpoint inhibitors: A Delphi study
2021-11-0113
OA
Delayed immune-related adverse events with an PD-1-based immunotherapy in melanoma
2021-07-0187
PREAI